Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/4/25 16:11 | 12/3/25 | ICCC | Health | Diagn | In Vitro & In Vivo Diagnostic | Te Boekhorst Paul Francis Olivier | ME | DO | P,CEO | P.am | 32 | 5.23 | 0 | 6 | 163 | 10 | D | ||||||||||||||
12/3/25 16:14 | 12/2/25 | ICCC | Health | Diagn | In Vitro & In Vivo Diagnostic | Te Boekhorst Paul Francis Olivier | ME | DO | P,CEO | P.m | 49 | 4.97 | 0 | 10 | New | 10 | D | ||||||||||||||
11/28/25 08:12 | 11/25/25 | ICCC | Health | Diagn | In Vitro & In Vivo Diagnostic | Tomsche David Scott | ME | D | P | 16 | 4.76 | 0 | 3 | 3 | 131 | M | |||||||||||||||
6/12/25 17:09 | 6/12/25 | ICCC | Health | Diagn | In Vitro & In Vivo Diagnostic | Gathagan Bryan K. | ME | D | P | 6 | 6.32 | 0 | 1 | New | 1 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |